Azlocillin
From Wikipedia, the free encyclopedia
 |
|
|
Azlocillin
|
|
| Systematic (IUPAC) name | |
| 3,3-dimethyl-6-oxo-7- [2-(2-oxoimidazolidin-1-yl) carbonylamino-2-phenyl-acetyl] amino- 2-thia-5-azabicyclo[3.2.0] heptane-4-carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C20H23N5O6S |
| Mol. mass | 461.493 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Azlocillin is an acylampicillin antibiotic with an extended spectrum of activity and greater in vitro potency than the carboxy penicillins. Azlocillin is similar to mezlocillin and piperacillin. It demonstrates antibacterial activity against a broad spectrum of bacteria, including Pseudomonas aeruginosa and, in contrast to most cephalosporins, exhibits activity against enterococci.
|
|||||||||||
 |
This molecular or cell biology article is a stub. You can help Wikipedia by expanding it. |
 |
This antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
